UPDATE: GlaxoSmithKline Shuts Australian Packaging Site
GlaxoSmithKline Shuts Australia Packaging Site
GlaxoSmithKline Shuts Australian Tablet-Packing Site
Research and Markets: Analyzing the Chemical Industry in the UK 2013
Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement
Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement
Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact
Research and Markets: Ion Channel Modulators - Global Strategic Business Report - 2013-2018
GlaxoSmithKline Files Drug Application for UMEC in US
My name is Simon, I'm your operator today. The format of the call will be some opening remarks from Andrew and Simon and (technical difficulty)